Form D · Biotechnology
Profound Medical Corp.
Mississauga, A6 · CIK 0001628808
Offering snapshot reported Oct 5, 2017 · SEC filing
- Reported sold
- $877K Offering amount: $877K
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 20, 2017 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 5, 2017 | Initial | $877,471 | No comparison | 16 | SEC filing |
| Oct 5, 2017 | Amendment | $877,471 | $0vs Oct 5, 2017 | 16 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $52.6K
- Finders' fees
- $0
- Form D file number
- 021-296067
This assumes Canadian/U.S. exchange rate of $1/1.2536. It does not reflect over-allotment option, which is exercisable until October 20, 2017.
Units (common shares and warrants to purchase common shares)
Underwriting fees paid by the issuer in respect of U.S. subscribers
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| CIBC World Markets Inc. | 16190 | CIBC World Markets Corp. · CRD 630 |
Source: Form D, filed Oct 5, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Curran | Director |
| Rashed Dewan | Executive |
| Kenneth Galbraith | Director |
| Damian Lamb | Director |
| Arun Menawat | Director, Executive |
| Jean Francois Pariseau | Director |
| Samira Sakhia | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Mississauga, A6, L4W 5K5